April 26, 2023 03:48 PM EDT
R&D

Fol­low­ing CRL, Form 483 re­veals more qual­i­ty is­sues at Alvotech’s pro­duc­tion fa­cil­i­ty in Ice­land

Tyler Patchen

News Reporter

An­oth­er Form 483 for the Ice­landic biosim­i­lar man­u­fac­tur­er Alvotech’s man­u­fac­tur­ing fa­cil­i­ty has shed more light on a re­cent com­plete re­sponse let­ter from the FDA …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times